RESUMEN
Passive transfer of immunity is essential for the short- and long-term health of dairy calves. The objective of this study was to evaluate factors associated with colostrum quality and passive transfer status of US heifer calves. This study included 104 operations in 13 states that participated in the calf component of the National Animal Health Monitoring System's Dairy 2014 study. This 18-mo longitudinal study included 1,972 Holstein heifer calves from birth to weaning. Multivariable mixed linear regression models were selected using backward elimination model selection after univariate screening to determine which factors were associated with colostrum IgG and serum IgG concentrations. The mean colostrum IgG concentration was 74.4 g/L with 77.4% of colostrum samples having IgG concentrations >50 g/L. The final model for colostrum IgG included colostrum source and a categorized temperature-humidity index value (cTHI) for the month before calving. Mean colostrum IgG concentrations were highest for dams in third and higher lactations (84.7 g/L) and lowest for commercial colostrum replacers (40.3 g/L). Colostrum IgG concentrations were highest for cTHI ≥70 (72.6 g/L) and lowest for cTHI <40 (64.2 g/L). The mean serum IgG concentration was 21.6 g/L, with 73.3% of calves having serum IgG concentrations >15 g/L. The final model for serum IgG concentration included region, heat treatment of colostrum, colostrum source, timing to first feeding, volume of colostrum fed in the first 24 h, age of the calf at blood sampling, and colostrum IgG concentration. Mean serum IgG concentrations were highest for calves that received colostrum from first-lactation dams (25.7 g/L) and lowest for calves fed commercial colostrum replacer (16.6 g/L). Serum IgG concentrations were higher for calves fed heat-treated colostrum (24.4 g/L) than for calves fed untreated colostrum (20.5 g/L). Serum IgG concentration was positively associated with the volume of colostrum fed in the first 24 h and colostrum IgG concentration, and negatively associated with the number of hours from birth to colostrum feeding and age (days) at blood collection. Dairy producers should be encouraged to measure the quality of colostrum before administering it to calves and to measure serum IgG or a proxy such as serum total protein or Brix to evaluate passive immunity and colostrum management programs.
Asunto(s)
Bovinos , Calostro/inmunología , Inmunización Pasiva/veterinaria , Inmunoglobulina G/sangre , Animales , Animales Recién Nacidos , Bovinos/inmunología , Femenino , Estudios Longitudinales , Embarazo , DesteteRESUMEN
The study objective was to evaluate average daily gain (ADG) in dairy heifer calves based on health, feeding, management practices, and environmental factors. This study included 102 operations in 13 states that participated in the calf component of the National Animal Health Monitoring System's Dairy 2014 study. This 18-mo longitudinal study included 1,410 Holstein heifer calves monitored from birth to weaning. The mean ADG from birth to final weight was 0.74 kg/d. Backward elimination model selection in Proc Mixed after univariate screening determined factors that significantly affected ADG. The final model included dam lactation number, singleton versus twin birth, bedding type, Giardia and Cryptosporidium fecal shedding, disease events, a categorized average temperature-humidity index for the preweaning period (pTHI), amount of protein in the liquid diet (kg/d), milk pasteurization, direct-fed microbials, and the interaction between milk pasteurization and direct-fed microbials. After controlling for other independent variables in the model, calves born to first-lactation dams gained less (0.60 kg/d) than calves from second- (0.65 kg/d) or third- or greater-lactation (0.64 kg/d) dams. Singleton calves gained 0.07 kg/d more than twins. Calves bedded with sand or no bedding gained less (0.49 kg/d) than calves on all other bedding types. Calves negative for Cryptosporidium or Giardia at the time of sampling gained 0.03 or 0.02 kg/d more, respectively, than calves that were positive for Cryptosporidium or Giardia. Calves with no disease events gained 0.07 kg/d more than calves with one or more disease events. Calves experiencing an average pTHI <50 gained more (0.67 kg/d) than calves experiencing an average pTHI from 50 to 69 (0.62 kg/d), or ≥70 (0.59 kg/d). Within the range of observed kilograms of protein fed per day in the liquid diet, every additional 0.1 kg of protein fed per day equated to 0.02 kg/d of gain. Calves fed milk replacer with a direct-fed microbial gained less (0.44 kg/d) than calves fed milk replacer without a direct-fed microbial (0.60 kg/d) and calves fed pasteurized or unpasteurized milk regardless of direct-fed microbial use. These results highlight the importance of feeding a quantity and quality of a liquid diet to achieve optimal growth, keeping calves free of disease, the type or status of bedding, and mitigating the effects of temperature and humidity on preweaning ADG.
Asunto(s)
Animales Lactantes/crecimiento & desarrollo , Bovinos/crecimiento & desarrollo , Alimentación Animal , Animales , Dieta , Femenino , Estudios Longitudinales , Leche , DesteteRESUMEN
OBJECTIVE: Assessment of HIV prevalence and associated risk behaviours among female commercial sex workers (FCSW) across major cities in South America. METHODS: Seroepidemiological, cross sectional studies of 13 600 FCSW were conducted in nine countries of South America during the years 1999-2002. Participants were recruited in brothels, massage parlours, hotels, and streets where anonymous questionnaires and blood samples were collected. HIV infection was determined by enzyme linked immunosorbent assay (ELISA) screening and western blot confirmatory tests. RESULTS: The overall HIV seroprevalence was 1.2% (range 0.0%-4.5%). The highest HIV seroprevalences were reported in Argentina (4.5%) and Paraguay (2.6%); no HIV infected FCSW were detected in Venezuela and Chile. Consistent predictors of HIV seropositivity were: (1) a previous history of sexually transmitted infections (STI, AORs = 3.8-8.3), and (2) 10 years or more in commercial sex work (AORs = 2.2-24.8). In addition, multiple (> or =3) sexual contacts (AOR = 5.0), sex with foreigners (AOR = 6.9), use of illegal drugs (AOR = 3.2), and marijuana use (AOR = 8.2) were associated with HIV seropositivity in Southern Cone countries. CONCLUSIONS: Consistently low HIV seroprevalences were detected among FCSW in South America, particularly in the Andean region. Predictors of HIV infection across the continent were STI and length of commercial sex work; however, use of illegal drugs, especially marijuana, and sexual contacts with foreigners were also found to be associated risk factors in the Southern Cone region. Interventions for the control of HIV and other STI need to be region and country specific; drug use appears to have an ever increasing role in the spread of HIV among heterosexually active populations.
Asunto(s)
Infecciones por VIH/epidemiología , Seroprevalencia de VIH , VIH-1 , Trabajo Sexual/estadística & datos numéricos , Adulto , Western Blotting , Ensayo de Inmunoadsorción Enzimática , Métodos Epidemiológicos , Femenino , Humanos , Factores de Riesgo , América del Sur/epidemiologíaRESUMEN
Programmes for the surveillance of Aedes aegypti (L.) often focus on residential areas, ignoring non-residential sites. Between November 2003 and October 2004, pupal/demographic surveys were therefore conducted in non-residential sites in the Peruvian city of Iquitos. The sampled sites included schools, factories, ports, public markets, petrol stations, commercial zones, airports, government buildings, animal-production areas, and recreational areas. Compared with the residential sites that had been surveyed a few years earlier, the non-residential sites generally had fewer pupae/ha, even though pupae were found in a high percentage of the sites investigated. Nonetheless, although <56 pupae/ha were observed in the industrial, commercial, recreational and school sites, the river boats in the ports and the areas in and around public markets sometimes had pupal abundances (of 122-213 pupae/ha) that were comparable with those previously recorded in the residential sites. When the relative production of Ae. aegypti was calculated by container type and characteristic (lidded/lidless, indoors/outdoors, and water-use patterns), no single container category was found to be a major producer of Ae. aegypti, with the exception of flower vases in cemeteries. In general, almost all (97%) of the pupae collected in the non-residential sites came from unlidded containers, although 91% of those collected in river boats came from lidded storage areas. With the exception of lumber mills, plant nurseries and markets (where only 39%-60% of the pupae were collected outdoors), >70% of pupal production was outdoors. In commercial areas, 41% of the pupae came from manually-filled containers, compared with <12% in residential sites. These results indicate that non-residential sites can be highly productive for Ae. aegypti and that the role of such sites in dengue transmission requires further investigation.
Asunto(s)
Aedes , Dengue , Insectos Vectores , Animales , Ciudades , Dengue/epidemiología , Dengue/prevención & control , Dengue/transmisión , Artículos Domésticos , Humanos , Perú/epidemiología , Vigilancia de la Población/métodos , Pupa , Salud Urbana , Abastecimiento de AguaRESUMEN
BACKGROUND: Transfusion-transmitted infections (TTIs) constitute a major health problem worldwide where routine screening of blood or blood products is improperly done, and where non-medical injecting medications and/or drug use are prevalent. Prevalence and risk factors vary by geographic location and by the specific TTI (including HIV-1, HBV, HCV and HTLV-I). OBJECTIVE: To determine the prevalence and risk factors associated with TTIs among a sample of multi-transfused adult patients in Peru. STUDY DESIGN: A cross-sectional multi-center study was conducted across seven major hospitals in Peru from February 2003 to September 2004. Self-reported behavior information (medical procedures, number of sexual partners, and drug use history) was analyzed, along with a review of exposure history from hospital medical records. Prevalences were calculated by TTI for different exposures, along with unadjusted and adjusted odds ratios for infection risk. RESULTS: Overall, 192 (54.7%) of 351 multi-transfused patients were found infected with one or more TTIs. Number of transfusion units, years of transfusion history (6 or more), and number of treatment facilities (2 or more) were associated with HCV infection. Hemodialysis history was a common risk factor associated with HBV, HCV and HTLV-I infection. HIV infection was associated only with total number of transfusion units received. CONCLUSIONS: High prevalences of HBV and HCV infection were found among Peruvian multi-transfused patients and were associated with a past history and number of blood transfusions, as well as with past hemodialysis procedures. TTIs continue to represent a significant public health problem in Peru. Continued vigilant attention to blood safety procedures, including universal screening and health care provider education, is recommended.
Asunto(s)
Anticuerpos Antivirales/sangre , Anticuerpos Anti-VIH/sangre , Infecciones por VIH/epidemiología , Infecciones por HTLV-I/epidemiología , Anticuerpos contra la Hepatitis B/sangre , Hepatitis B/epidemiología , Anticuerpos contra la Hepatitis C/sangre , Hepatitis C/epidemiología , Virus Linfotrópico T Tipo 1 Humano/inmunología , Diálisis Renal , Reacción a la Transfusión , Adolescente , Adulto , Estudios Transversales , Transmisión de Enfermedad Infecciosa , Femenino , Infecciones por VIH/transmisión , Infecciones por HTLV-I/transmisión , Hepatitis B/transmisión , Hepatitis C/transmisión , Hospitales , Humanos , Masculino , Persona de Mediana Edad , Perú/epidemiología , Factores de RiesgoRESUMEN
OBJECTIVES: Sex among men constitutes an important route of transmission for HIV type 1 (HIV-1) in Latin America. Seeking better understanding of risk behaviours in this region, we determined the seroprevalence, potential risk factors, and geographic distribution of HIV-1 among groups of men who have sex with men (MSM). METHODS: Seroepidemiological, cross sectional studies of 13,847 MSM were conducted in seven countries of South America during the years 1999-2002. Volunteers were recruited in city venues and streets where anonymous questionnaires and blood samples were obtained. HIV-1 infection was determined by enzyme linked immunosorbent assay (ELISA) screening and western blot (WB) confirmatory tests. RESULTS: HIV-1 seroprevalence varied widely (overall 12.3%, range 11.0%-20.6%). The highest HIV-1 seroprevalence was noted in Bolivia (20.6%) and the lowest in Peru (11.0%). Predictors of HIV-1 infection varied among countries; however, a history of previous sexually transmitted disease (STD) was associated with a consistent increased risk (ORs=1.9-2.9, AORs=1.8-2.7). Multiple weekly sexual contacts was found to represent a secondary risk factor in Ecuador, Peru, and Argentina (ORs=1.6-2.9, AORs=1.6-3.1), whereas use of drugs such as cocaine was found to increase risk in Bolivia, Uruguay, and Paraguay (ORs=2.5-6.5, AORs=2.6-6.1). CONCLUSION: The results of this study illustrate an elevated HIV-1 seroprevalence among MSM participants from Andean countries. A previous STD history and multiple partners predicted HIV-1 infection in the seven countries of South America. In Southern Cone countries, HIV-1 infection was also associated with use of illegal drugs such as cocaine.
Asunto(s)
Infecciones por VIH/epidemiología , Seroprevalencia de VIH , VIH-1 , Homosexualidad Masculina/estadística & datos numéricos , Adolescente , Adulto , Anciano , Humanos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Factores de Riesgo , Parejas Sexuales , América del Sur/epidemiología , Trastornos Relacionados con Sustancias/epidemiología , Sexo Inseguro/estadística & datos numéricos , Salud UrbanaRESUMEN
HIV subtypes B, F, and BF recombinants have been previously reported in South America. This report describes the presence of HIV-1 subtype C infection in the countries of Argentina, Uruguay, and Paraguay dating back to at least 1999. Surveillance for uncommon non-B/non-F subtype viruses circulating in South America has been conducted in samples obtained from nine countries. Peripheral blood mononuclear cells (PBMC), dried filter paper (FP), and fresh blood (FB) samples were collected from HIV-positive patients from Ecuador, Colombia, Venezuela, Peru, Chile, Bolivia, Argentina, Uruguay, and Paraguay. From a total of 2962 HIV seropositive samples examined during a 9-year period (1995-2003), only 11 (0.4%) were found to be infected with non-B/non-F HIV variants. Eight of these 11 strains were determined to be subtype C by heteroduplex mobility assay (HMA). Five of these 8 strains were further characterized by sequencing and phylogenetic analysis of the protease (Pro) and reverse transcriptase (RT) region of the genome and two were sequenced full length. One of the strains was found to be a unique BC recombinant. The spread of a third subtype of HIV, subtype C, should raise the question of its potential future role in the HIV epidemic in this region.
Asunto(s)
Infecciones por VIH/epidemiología , Infecciones por VIH/virología , VIH-1/clasificación , VIH-1/genética , Adulto , Argentina/epidemiología , Femenino , Proteasa del VIH/genética , Transcriptasa Inversa del VIH/genética , Análisis Heterodúplex , Humanos , Masculino , Persona de Mediana Edad , Datos de Secuencia Molecular , Paraguay/epidemiología , Filogenia , Análisis de Secuencia de ADN , Uruguay/epidemiologíaRESUMEN
Quinolinyl chalcones were synthesized and evaluated for their inhibition of the Plasmodium falciparum cystein protease falcipain and their activity against cultured P. falciparum parasites. They were also tested for in vivo efficacy in a rodent P. berghei model. Their activity against falcipain and as antimalarials was moderate, but antimalarial activity was probably not due to the inhibition of falcipain and may follow a different mechanism. 1-(2,4-Dichlorophenyl)-3-[3-(2-chloro-6,7-dimethoxiquinolinyl)]-2-propen-1-one 3j was the most promising compound among those here reported (IC50 19.0 microM).
Asunto(s)
Antimaláricos/síntesis química , Antimaláricos/farmacología , Chalcona/análogos & derivados , Chalcona/farmacología , Quinolonas/farmacología , Animales , Antimaláricos/química , Antimaláricos/uso terapéutico , Chalcona/síntesis química , Chalcona/uso terapéutico , Diseño de Fármacos , Evaluación Preclínica de Medicamentos , Endopeptidasas/metabolismo , Cromatografía de Gases y Espectrometría de Masas , Concentración 50 Inhibidora , Espectroscopía de Resonancia Magnética , Malaria/tratamiento farmacológico , Masculino , Ratones , Ratones Endogámicos BALB C , Plasmodium berghei/efectos de los fármacos , Plasmodium falciparum/efectos de los fármacos , Quinolonas/síntesis química , Quinolonas/química , Quinolonas/uso terapéutico , Relación Estructura-ActividadRESUMEN
During May 1998, we conducted a case-control study of 357 participants from 60 households during an outbreak of acute bartonellosis in the Urubamba Valley, Peru, a region not previously considered endemic for this disease. Blood and insect specimens were collected and environmental assessments were done. Case-patients (n = 22) were defined by fever, anemia, and intra-erythrocytic coccobacilli seen in thin smears. Most case-patients were children (median age = 6.5 years). Case-patients more frequently reported sand fly bites than individuals of neighboring households (odds ratio [OR] = 5.8, 95% confidence interval [CI] = 1.2-39.2), or members from randomly selected households > or = 5 km away (OR = 8.5, 95% CI = 1.7-57.9). Bartonella bacilliformis isolated from blood was confirmed by nucleotide sequencing (citrate synthase [g/tA], 338 basepairs). Using bacterial isolation (n = 141) as the standard, sensitivity, specificity, and positive predictive value of thin smears were 36%, 96%, and 44%, respectively. Patients with clinical syndromes compatible with bartonellosis should be treated with appropriate antibiotics regardless of thin-smear results.
Asunto(s)
Infecciones por Bartonella/epidemiología , Bartonella/aislamiento & purificación , Brotes de Enfermedades , Adolescente , Adulto , Infecciones por Bartonella/diagnóstico , Infecciones por Bartonella/fisiopatología , Estudios de Casos y Controles , Niño , Preescolar , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Perú/epidemiología , Factores de RiesgoRESUMEN
Between November 1993 and March 1994, a cluster 6 pediatric patients with acute febrile illnesses associated with rashes was identified in Jujuy Province, Argentina. Immunohistochemical staining of tissues confirmed spotted fever group rickettsial infection in a patient with fatal disease, and testing of serum of a patient convalescing from the illness by using an indirect immunofluorescence assay (IFA) demonstrated antibodies reactive with spotted fever group rickettsiae. A serosurvey was conducted among 16 households in proximity to the index case. Of 105 healthy subjects evaluated by IFA, 19 (18%) demonstrated antibodies reactive with rickettsiae or ehrlichiae: 4 had antibodies reactive with Rickettsia rickettsii, 15 with Ehrlichia chaffeensis, and 1 with R. typhi. Amblyomma cajennense, a known vector of R. rickettsii in South America, was collected from pets and horses in the area. These results are the first to document rickettsial spotted fever and ehrlichial infections in Argentina.
Asunto(s)
Ehrlichia chaffeensis/aislamiento & purificación , Ehrlichiosis/epidemiología , Rickettsia rickettsii/aislamiento & purificación , Fiebre Maculosa de las Montañas Rocosas/epidemiología , Adolescente , Adulto , Anticuerpos Antibacterianos/sangre , Argentina/epidemiología , Niño , Preescolar , Ehrlichia chaffeensis/inmunología , Resultado Fatal , Femenino , Técnica del Anticuerpo Fluorescente , Humanos , Técnicas para Inmunoenzimas , Masculino , Rickettsia rickettsii/inmunología , Fiebre Maculosa de las Montañas Rocosas/fisiopatología , Estudios SeroepidemiológicosRESUMEN
After the discovery of vitamin A in 1913, the yellow pigments of fruits and vegetables were soon implicated as compounds with similar nutritional effects. beta-Carotene was shown to be converted into vitamin A by Moore in 1929, and the chemical structures of both vitamin A and beta-carotene were determined two years later. Thus, the sole function of beta-carotene in human health was considered to be its conversion into vitamin A. On the basis of observational epidemiologic studies, conducted in the mid-1970s, however, carotenoids were implicated as protective agents, first against lung cancer and then against a variety of other chronic diseases. Intervention trials employing beta-carotene, however, either have shown no preventive effect or indeed, in two cases, have enhanced the incidence of lung cancer in middle-aged male smokers and asbestos workers. The possible protective action of carotenoids can be attributed to their properties as singlet oxygen quenchers and as antioxidants, whereas their cancer-enhancing actions in lung can be ascribed to the prooxidant action of carotenoid free radicals in damaged cells. Apart from chronic diseases, beta-carotene has shown significant therapeutic value in individuals suffering from photosensitivity disorders and provides temporary relief to persons afflicted with leukoplakia. A part from a medical context, the colored carotenoids found in many living organisms and in many foods delight both the eye and the palate. Thus, human health and the enjoyment of life are greatly benefited by the presence of these interesting pigments in nature, whether or not they ultimately prove to have more specific protective effects against chronic diseases.
Asunto(s)
Carotenoides/uso terapéutico , Antioxidantes/uso terapéutico , Carotenoides/farmacología , Enfermedad Crónica , Humanos , Leucoplasia/tratamiento farmacológico , Degeneración Macular/tratamiento farmacológico , Neoplasias/inducido químicamente , Neoplasias/prevención & control , Trastornos por Fotosensibilidad/tratamiento farmacológico , Vitamina A/farmacología , Vitamina A/uso terapéuticoRESUMEN
Our current knowledge about the bioavailability of provitamin A carotenoids in foods is insufficient, fragmentary and difficult to interpret. Past methods of estimating the vitamin A value of food carotenoids suffer both from uncertainty about the meaning of bioavailability and from the inadequacy of the indicators used in its determination. Reported conversion ratios of beta-carotene to vitamin A in humans in vivo, depending on conditions, range from 2:1 to 26:1 (microgram/microgram). Thus, the ratio of 6:1, devised by the World Health Organization, must be considered as a rough average estimate that is not applicable to all diets. Strategies to increase the dietary intake of carotenoid-containing foods should include measures to enhance carotenoid bioavailability.
Asunto(s)
Carotenoides/farmacocinética , Vitamina A/farmacocinética , Absorción , Animales , Disponibilidad Biológica , Dieta , Humanos , Vitamina A/administración & dosificación , beta Caroteno/farmacocinéticaRESUMEN
Acridinediones have previously been shown to have potent antimalarial activity. A series of sulfur isosteres of acridinediones have been synthesized and evaluated for their inhibition of the Plasmodium falciparum cysteine protease falcipain and for their antimalarial activity. A number of these phenothiazines inhibited falcipain and demonstrated activity against cultured P. falciparum parasites at low micromolar concentrations. We propose that the compounds exerted their antimalarial effects by two mechanisms, one of which involves the inhibition of falcipain and a consequent block in parasite degradation of hemoglobin. These compounds and related phenothiazines are worthy of further study as potential antimalarial agents.
Asunto(s)
Antimaláricos/síntesis química , Cisteína Endopeptidasas/metabolismo , Inhibidores de Cisteína Proteinasa/síntesis química , Fenotiazinas/química , Plasmodium falciparum/enzimología , Animales , Antimaláricos/farmacología , Células Cultivadas , Inhibidores de Cisteína Proteinasa/farmacología , Fenotiazinas/farmacología , Plasmodium falciparum/efectos de los fármacosRESUMEN
Human bartonellosis is a classically biphasic disease caused by infection with the alpha-2 Proteobacteria Bartonella bacilliformis, which is phylogenetically related to the etiologic agents of cat scratch disease, bacillary angiomatosis, and trench fever. In Ecuador, typical bartonellosis has remained endemic for the past century in highland provinces near the Peruvian border. During the past six years, public health officials have noted an increasing number of atypical cases in which monophasic verrucous cutaneous disease is the only clinical manifestation. Epidemiologic, immunologic, histopathologic, and molecular biological studies have confirmed the presence of sporadic, atypical bartonellosis in residents of the lowland province of Manabi, where archeologic evidence exists of bartonellosis in pre-Colombian times. Between 1987 and 1995, 11 cases of cutaneous bartonellosis were investigated and serologic studies were done on 224 persons from five villages, two lowland and three highland. In the lowland village of Pajan in the province of Manabi, there was a 21% seropositivity proportion in contacts of index cases. These combined data suggest that bartonellosis is significantly under-reported due to the existence of mild clinical disease, possibly associated with less virulent bacterial strains, which are now disseminating or re-emerging in previously disease-free areas.
Asunto(s)
Infecciones por Bartonella/epidemiología , Anticuerpos Antibacterianos/análisis , Bartonella/genética , Bartonella/inmunología , Bartonella/ultraestructura , Infecciones por Bartonella/diagnóstico , ADN Bacteriano/análisis , Ecuador/epidemiología , Humanos , Reacción en Cadena de la Polimerasa , ARN Ribosómico 16S/genética , Estudios SeroepidemiológicosRESUMEN
In response to a potential dengue fever outbreak in south Texas during 1995, the susceptibilities of Aedes aegypti and Aedes albopictus to commonly used mosquito adulticides were assessed. Larvae collected from the Lower Rio Grande Valley of Texas and Mexico were reared to adults and tested against susceptible laboratory strains at Texas A&M University. Resistance ratios at both the LC50 and LC95 rates were all less than 10, indicating that adult populations of both species are still susceptible to malathion, chlorpyrifos, resmethrin, and permethrin.
Asunto(s)
Aedes , Insecticidas , Control de Mosquitos , Animales , Cloropirifos , Resistencia a los Insecticidas , Malatión , México , Permetrina , Piretrinas , TexasRESUMEN
We reviewed the clinical course, physical findings, and hematologic values in 16 pediatric patients with hemoglobin C disease, all but one identified by a newborn hemoglobinopathy screening program. The patients had a few symptoms or physical findings. Height and weight percentiles were normal. Patients typically had a mild hemolytic anemia characterized by microcytosis and target cells.
Asunto(s)
Enfermedad de la Hemoglobina C/sangre , Talasemia beta/sangre , Adolescente , Estatura , Peso Corporal , Estudios de Casos y Controles , Niño , Preescolar , Estudios de Cohortes , Eritrocitos/patología , Femenino , Ferritinas/sangre , Estudios de Seguimiento , Enfermedad de la Hemoglobina C/diagnóstico , Enfermedad de la Hemoglobina C/fisiopatología , Hemoglobinas/análisis , Humanos , Lactante , Recién Nacido , Masculino , Examen Físico , Recuento de Reticulocitos , Talasemia beta/diagnóstico , Talasemia beta/fisiopatologíaRESUMEN
An infant with a diagnosis of acute infantile cardiomyopathy was subsequently shown to have mucopolysaccharidosis VI. The mucopolysaccharidoses should be included in the differential diagnosis of infantile cardiomyopathy.